难治性多态性移植后淋巴增生性疾病的临床试验
总计1648个结果
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of Health (NIH)主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford University主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销
-
Cellular Biomedicine Group Ltd.Chinese PLA General Hospital未知
-
Leland Metheny尚未招聘淋巴增生性疾病 | 骨髓增生异常综合症 | 骨髓增殖性肿瘤 | 同种异体干细胞移植候选人 | 急性髓系/淋巴细胞白血病美国
-
Shenzhen University General Hospital招聘中
-
Kite, A Gilead Company招聘中
-
National Cancer Institute (NCI)暂停
-
National Cancer Institute (NCI)撤销复发性经典霍奇金淋巴瘤 | 难治性经典霍奇金淋巴瘤
-
Gilead Sciences完全的
-
Sumithira VasuNational Cancer Institute (NCI)招聘中复发性 B 型急性淋巴细胞白血病 | 难治性 B 型急性淋巴细胞白血病 | 难治性慢性淋巴细胞白血病 | 复发性非霍奇金淋巴瘤 | 难治性非霍奇金淋巴瘤 | 复发性急性淋巴细胞白血病 | 难治性急性淋巴细胞白血病 | 复发性高级 B 细胞淋巴瘤 | 难治性高级 B 细胞淋巴瘤 | 复发性慢性淋巴细胞白血病 | 复发性 B 细胞幼淋巴细胞白血病 | 难治性 B 细胞幼淋巴细胞白血病 | 复发性转化性慢性淋巴细胞白血病 | 难治性转化性慢性淋巴细胞白血病 | 复发性惰性非霍奇金淋巴瘤 | 难治性惰性非霍奇金淋巴瘤美国
-
Shahid Beheshti University of Medical Sciences尚未招聘
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.招聘中
-
Karyopharm Therapeutics Inc招聘中
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.招聘中
-
Amgen终止
-
Precision BioSciences, Inc.终止
-
Allogene Therapeutics主动,不招人
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.未知
-
National Cancer Institute (NCI)完全的
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical University招聘中
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.招聘中
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of Washington招聘中
-
BeiGene招聘中
-
University of ChicagoNational Cancer Institute (NCI)招聘中
-
Allogene Therapeutics主动,不招人
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University School of... 和其他合作者主动,不招人